Status:
COMPLETED
RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy
Lead Sponsor:
AstraZeneca
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
Brief Summary
This NIS is a multi-centre, observational, descriptive, cross-sectional study including all consecutive patients with Acute Coronary Syndrome (ACS) and a single-arm, prospective, longitudinal cohort s...
Eligibility Criteria
Inclusion
- Part A,B: Subjects whose data have been entered in the Russian ACS Registry
- PART A,B: Discharged from hospital after MI with ST-segment elevation (STEMI), MI NST segment elevation (NSTEMI) or Unstable angina. Hospitalized during 24 hours of ACS symptoms onset
- Part B: Patients on ticagrelor at the time of discharge from hospital
Exclusion
- The existence of serious / severe concomitant diseases which can in the short term (i.e. within 6 months) limit the duration of life
- Current participation in a clinical trial with a non-licensed investigational medicinal product
Key Trial Info
Start Date :
April 13 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 29 2018
Estimated Enrollment :
5470 Patients enrolled
Trial Details
Trial ID
NCT02288260
Start Date
April 13 2015
End Date
July 29 2018
Last Update
July 15 2019
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Arkhangelsk, Russia
2
Research Site
Cheboksary, Russia
3
Research Site
Irkutsk, Russia
4
Research Site
Kazan', Russia